““this guidance focuses on the use of patient-level data from other clinical trials or from real-world data (RWD) sources, such as registries as well as electronic health records (EHRs) and medical claims.” ”
Page 1 of PDF. Clearly says “other clinical trial as well as RWD sources “
GPha, I’ve had Mani on Ignore for several years now. I don’t believe he will read the FDA guidance, even though I quoted the FDA guidance and I included the link to the guidance in my post.
But, just in case he wants to read the guidance, I’ll post the link again below: